Guidance

Actions to contain carbapenemase-producing Enterobacterales (CPE)

This framework focuses on carbapenemase-producing Enterobacterales that spread rapidly in healthcare settings.

• From: UK Health Security Agency
• Published: 1 October 2020
• Last updated: 28 September 2022 — See all updates

Documents

Framework of actions to contain carbapenemase-producing Enterobacterales

Ref: UKHSA publications gateway number GOV-10737

PDF, 785 KB, 78 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The increased incidence of carbapenemase-producing Enterobacterales (CPE) has significant cost and operational implications for healthcare providers.

Unless action is taken and we learn from experiences elsewhere in the world, rapid spread of CPE will pose an ever-increasing threat to public health and medical treatment pathways in the UK.

The framework sets out a range of measures, that if implemented well, will help health and social care providers minimise the impact of CPE.

Published 1 October 2020
Last updated 28 September 2022 + show all updates

1. 28 September 2022

   Added updated framework and changed branding to UKHSA.

2. 1 October 2020

   First published.